Skip to main content

Table 1 Baseline clinical characteristics of the patients

From: Prognostic markers of heart failure in patients undergoing peritoneal dialysis

Total, n 29
Female, n (%) 8 (27.6)
Age (years) 64.14 ± 14.42
BMI (kg/m2) 23.60 ± 3.057
DM, n (%) 11 (37.9)
Nephrosclerosis, n (%) 9 (31.0)
PD duration (months) 12.04 ± 7.589
D/P ratio 0.7273 ± 0.2034
D/D ratio 0.3769 ± 0.1324
Weekly Kt/V urea 1.813 ± 0.4844
Weekly CCr (L/week/1.73m2) 86.31 ± 36.00
Urine volume (mL/day) 919.8 ± 383.3
ARB, n (%) 22(75.9)
Statin, n (%) 13 (44.8)
Diuretic (%) 25 (86.2)
Iron supplementation, n (%) 6 (20.7)
LAD (mm) 37.83 ± 6.042
LVMI (g/m2) 126.7 ± 34.14
EF (%) 66.99 ± 9.917
E/e' 14.98 ± 8.113
CI 3.332 ± 0.7997
  1. BMI body mass index, DM diabetes mellitus, PD peritoneal dialysis, ARB angiotensin II receptor blocker, LAD left atrial dimension, LVMI left ventricular mass index, EF ejection fraction, CI cardiac index